Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deep Genomics
Biotech
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
J&J exec to retire after 17 years. Bayer’s top biotech leader departs. Former Kite exec takes the reins of new biotech.
Gabrielle Masson
,
Andrea Park
,
Fraiser Kansteiner
Jun 14, 2024 8:30am
Deep Genomics puts forward AI model for generating RNA therapies
Sep 27, 2023 11:16am
Deep Genomics scores $180M to deliver programmable RNA therapies
Jul 28, 2021 10:13am
After Repare IPO success, Amplitude closes CA$200M fund
Jun 17, 2021 5:00am
AI biotech Deep Genomics unveils its 1st partner: BioMarin
Nov 17, 2020 8:30am
Novartis alums unveil their next act—Chutes & Ladders
Nov 6, 2020 9:30am